PBMs Are in Regulators’ Crosshairs But Are Regulators Missing the Point?

As our CEO and Co-Founder, Chris Blackley, writes, the consequences of failing to address pharmacy benefit managers’ use of market power to block competition and extract monopoly profits from payers and consumers will not be limited to drug costs – it will change all of healthcare for generations. See his full take in MedCity News.

Latest News

View all News